BSWA
ABBV icon

Bromfield Sneider Wealth Advisors’s AbbVie ABBV Stock Holding History

Bromfield Sneider Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-565
Closed -$92K – 93
2022
Q1 		$92K Buy
+565
New +$82.1K 0.1% 50

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bromfield Sneider Wealth Advisors's ABBV Position: Q2 2022 in Review

Bromfield Sneider Wealth Advisors sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 565 shares — an estimated $92K sold.

Bromfield Sneider Wealth Advisors first reported a position in ABBV in Q1 2022 and held it in 1 quarter. The position peaked at $92K in Q1 2022. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • Bromfield Sneider Wealth Advisors reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
  • Bromfield Sneider Wealth Advisors sold 565 AbbVie shares in Q2 2022, an estimated $92K.
  • Bromfield Sneider Wealth Advisors first reported a position in AbbVie in Q1 2022 and held it in 1 quarter.
  • Bromfield Sneider Wealth Advisors's AbbVie position peaked at $92K in Q1 2022.
  • 3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Bromfield Sneider Wealth Advisors's 13F filing for Q2 2022, filed 6 Jul 2022.